Pharmafile Logo

BTG

- PMLiVE

Boston Scientific makes $4.2bn play for UK’s BTG

Comes shortly after the company acquired US biotech Augmentix

- PMLiVE

BTG acquires Roxwood Medical

Will pay up to $80m for the catheter specialist

- PMLiVE

BTG rises on FDA approval of varicose vein therapy

Varithena receives green light in US

AstraZeneca and BGT shelve experimental sepsis drug

Decision follows CytoFab’s poor mid-stage clinical trial results

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links